John W. Raff
Fondateur chez Dovuro Seeds Pty Ltd.
Postes actifs de John W. Raff
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Dovuro Seeds Pty Ltd.
 Dovuro Seeds Pty Ltd. Agricultural Commodities/MillingProcess Industries Part of Nufarm Ltd., Dovuro Seeds Pty Ltd. is an Australian company that produces and wholesales canola seeds. The company is based in Horsham, Australia. The company was founded by John W. Raff. Dovuro Seeds was acquired by Nufarm Ltd. on April 26, 2006. | Fondateur | 05/01/2011 | - |
| Corporate Officer/Principal | - | 05/01/2011 | |
Nutrihealth Pty Ltd.
 Nutrihealth Pty Ltd. Agricultural Commodities/MillingProcess Industries Part of Nufarm Ltd., Nutrihealth Pty Ltd. is an Australian company that produces grains and agricultural products. The company was founded by John W. Raff. Nutrihealth was acquired by Nufarm Ltd. on April 26, 2006. | Fondateur | 05/01/2011 | - |
| Corporate Officer/Principal | - | 05/01/2011 | |
Paranta Biosciences Ltd.
 Paranta Biosciences Ltd. Pharmaceuticals: MajorHealth Technology Paranta Biosciences Ltd. engages in the research and development of novel biotherapeutic. t develops PB01 (recombinant human follistatin-288) for the treatment of fibrotic and inflammatory diseases. The company was founded in 2011 and is headquartered in Richmond, Australia. | Directeur/Membre du Conseil | - | - |
Historique de carrière de John W. Raff
Anciens postes connus de John W. Raff
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| STARPHARMA HOLDINGS LIMITED | Directeur/Membre du Conseil | 05/08/2009 | 17/06/2011 |
| Président | - | 05/08/2009 | |
| The Biomolecular Research Institute Ltd. | Corporate Officer/Principal | - | - |
| BioMelbourne Network | Président | 30/07/2009 | - |
Farmacule BioIndustries Pty Ltd.
 Farmacule BioIndustries Pty Ltd. Miscellaneous Commercial ServicesCommercial Services Farmacule BioIndustries Pty Ltd. Developed industrial and therapeutic proteins and biofuels. It engaged in developing molecular farming technology to produce proteins, biofuels and bioplastics in plants for various industrial, therapeutic and diagnostic applications. The company was founded in 2001 and was headquartered in Altona North, Australia. | Directeur/Membre du Conseil | - | - |
Formation de John W. Raff
| University of Melbourne | Doctorate Degree |
Statistiques
Internationale
| Australie | 9 |
Opérationnelle
| Director/Board Member | 3 |
| Corporate Officer/Principal | 3 |
| Chairman | 2 |
Sectorielle
| Health Technology | 3 |
| Process Industries | 3 |
| Commercial Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| STARPHARMA HOLDINGS LIMITED | Health Technology |
| Entreprise privées | 6 |
|---|---|
Farmacule BioIndustries Pty Ltd.
Farmacule BioIndustries Pty Ltd. Miscellaneous Commercial ServicesCommercial Services Farmacule BioIndustries Pty Ltd. Developed industrial and therapeutic proteins and biofuels. It engaged in developing molecular farming technology to produce proteins, biofuels and bioplastics in plants for various industrial, therapeutic and diagnostic applications. The company was founded in 2001 and was headquartered in Altona North, Australia. | Commercial Services |
Dovuro Seeds Pty Ltd.
Dovuro Seeds Pty Ltd. Agricultural Commodities/MillingProcess Industries Part of Nufarm Ltd., Dovuro Seeds Pty Ltd. is an Australian company that produces and wholesales canola seeds. The company is based in Horsham, Australia. The company was founded by John W. Raff. Dovuro Seeds was acquired by Nufarm Ltd. on April 26, 2006. | Process Industries |
Nutrihealth Pty Ltd.
Nutrihealth Pty Ltd. Agricultural Commodities/MillingProcess Industries Part of Nufarm Ltd., Nutrihealth Pty Ltd. is an Australian company that produces grains and agricultural products. The company was founded by John W. Raff. Nutrihealth was acquired by Nufarm Ltd. on April 26, 2006. | Process Industries |
| BioMelbourne Network | |
| The Biomolecular Research Institute Ltd. | |
Paranta Biosciences Ltd.
Paranta Biosciences Ltd. Pharmaceuticals: MajorHealth Technology Paranta Biosciences Ltd. engages in the research and development of novel biotherapeutic. t develops PB01 (recombinant human follistatin-288) for the treatment of fibrotic and inflammatory diseases. The company was founded in 2011 and is headquartered in Richmond, Australia. | Health Technology |
- Bourse
- Insiders
- John W. Raff
- Expérience
